Expert Interview
A Second Look: Discussing the potential of Johnson and Johnson's Spravato (esketamine nasal spray) as a monotherapy option for treatment resistant depression
Ticker(s): JNJInstitution: Columbia Psychiatric Associates (Private Practice)
- Psychiatrist in private practice in Columbia, South Carolina who manages 250 patients with major depressive disorder and 100 patients with Bipolar Depression.
- Specializes in outpatient depressive and anxiety disorders for adults over the age of 23.
- Familiar with the published literature for lumateperone in treating bipolar depression.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
